Bovie Medical Co. (BVX) Stock Price Down 4.2%
Shares of Bovie Medical Co. (NYSE:BVX) were down 4.2% during mid-day trading on Tuesday . The company traded as low as $4.26 and last traded at $4.31, with a volume of 84,659 shares. The stock had previously closed at $4.50.
A number of analysts recently issued reports on BVX shares. JMP Securities reissued an “outperform” rating and set a $5.00 price objective on shares of Bovie Medical in a report on Wednesday, August 3rd. Zacks Investment Research raised Bovie Medical from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th.
The company’s 50-day moving average is $2.88 and its 200 day moving average is $2.06. The stock’s market cap is $105.23 million.
In other news, insider John J. Mccarthy III acquired 90,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The stock was bought at an average price of $3.30 per share, with a total value of $299,475.00. Following the completion of the acquisition, the insider now directly owns 115,750 shares of the company’s stock, valued at approximately $381,975. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.